rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2000-11-28
|
pubmed:abstractText |
The anti-pruritic activity of emedastine difumarate was studied in mice. Emedastine (0.03-0.3 mg/kg) inhibited scratching induced by intradermal injection of histamine (100 nmol/site). Scratching induced by substance P (100 nmol/site) and leukotriene B(4) (0.03 nmol/site), but not by serotonin (100 nmol/site), was also suppressed by emedastine (0.03-0.3 mg/kg). Intradermal injection of substance P increased the cutaneous concentration of leukotriene B(4), which was not affected by emedastine. These results suggest that the inhibition by emedastine of substance P-induced itch-associated response is mediated by the blockade of leukotriene B(4) action. Anti-leukotriene B(4) action, as well as the anti-histamine action, may contribute to the anti-pruritic effects of emedastine.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0014-2999
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
406
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
149-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11011046-Animals,
pubmed-meshheading:11011046-Anti-Allergic Agents,
pubmed-meshheading:11011046-Benzimidazoles,
pubmed-meshheading:11011046-Dose-Response Relationship, Drug,
pubmed-meshheading:11011046-Histamine,
pubmed-meshheading:11011046-Injections, Intradermal,
pubmed-meshheading:11011046-Leukotriene B4,
pubmed-meshheading:11011046-Male,
pubmed-meshheading:11011046-Mice,
pubmed-meshheading:11011046-Mice, Inbred ICR,
pubmed-meshheading:11011046-Pruritus,
pubmed-meshheading:11011046-Serotonin,
pubmed-meshheading:11011046-Substance P
|
pubmed:year |
2000
|
pubmed:articleTitle |
Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice.
|
pubmed:affiliation |
Department of Applied Pharmacology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, 930-0194, Toyama, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|